Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.
about
The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentAbeta, oxidative stress in Alzheimer disease: evidence based on proteomics studiesRoles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease.Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer's disease.BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer's disease.Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's diseaseSubcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3βOxidative stress and β-amyloid protein in Alzheimer's disease.4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studiesPrimary phagocytosis of neurons by inflamed microglia: potential roles in neurodegenerationDistinct mechanisms determine organ left-right asymmetry patterning in an uncoupled way.Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of ageNeuronal death induced by nanomolar amyloid β is mediated by primary phagocytosis of neurons by microglia.Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.
P2860
Q26827320-0A4990E7-D0DB-4247-8729-2398C9383A2EQ27693922-D3102645-B30A-47C5-BF51-226BDF86C32BQ30394816-B19C9856-A8E5-4000-A535-BB6C8F55BFA1Q30446460-9D7C550F-09F6-4349-BEE6-B96CF3B126F9Q30451918-9A0A1C85-314C-470F-9337-EE6413588698Q36195468-F1DEE6A1-5947-4913-9B22-C91AEBDF1D9FQ36790844-571057DB-20F4-436F-96B7-063202EEE4A9Q36997908-3C7A0828-D233-4DD0-85F6-CEC8FD7663BCQ37685201-EA6C1F55-4E5D-4DC1-9B87-BE6E9B5BA899Q37928994-118C9B5E-12AC-4AE1-A944-A7218F51B1EDQ37960537-7B5B0E13-5EDB-4D95-88D9-EA599D970291Q37992053-B5DD1F83-418B-4A3B-974E-79B002404A9AQ38181993-DDBC5D8D-61FD-4943-A1E1-666852D5EDC3Q38793564-85000031-2EF7-4786-BD9B-DA5EE4D4CA75Q39246322-2B29AFCC-1DE8-4AC9-BE9D-1D12D50A1CFAQ51760895-FB602DDF-EC66-481B-A817-AF5D87A28E00
P2860
Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Age-related loss of phospholip ...... elevance to Alzheimer disease.
@ast
Age-related loss of phospholip ...... elevance to Alzheimer disease.
@en
type
label
Age-related loss of phospholip ...... elevance to Alzheimer disease.
@ast
Age-related loss of phospholip ...... elevance to Alzheimer disease.
@en
prefLabel
Age-related loss of phospholip ...... elevance to Alzheimer disease.
@ast
Age-related loss of phospholip ...... elevance to Alzheimer disease.
@en
P2093
P2860
P1476
Age-related loss of phospholip ...... elevance to Alzheimer disease.
@en
P2093
Christa M Studzinski
Daret St Clair
M Paul Murphy
Miranda L Bader Lange
William R Markesbery
P2860
P304
P356
10.1016/J.NBD.2010.01.004
P577
2010-01-18T00:00:00Z